BUY Akums Drugs and Pharmaceuticals — Ashish Kyal, Waves Strategy Advisors
byAshish Kyal, Waves Strategy AdvisorsHorizon: NA (inferred Swing (≤2wk))15 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·15 Sept · yesterday
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Akums Drugs and Pharmaceuticals
- BUY — Anand James, Geojit Investments22 Sept 2026 · ~2 weeks · target ₹860 · SL hit
- BUY — Sumeet Bagadia, Choice Broking15 Sept 2026 · ~2 weeks · target ₹865 · Expired
- BUY — Kush Bohra19 Aug 2026 · ~2 weeks · target ₹795 · Target hit
- BUY — Citigroup18 Aug 2026 · ~1 year · target ₹840 · Active
- BUY — Citigroup18 Aug 2026 · ~1 year · target ₹860 · Active
More from Ashish Kyal, Waves Strategy Advisors
- BUY Persistent Systems30 Oct 2026 · ~2 weeks · target ₹6,325 · Active
- BUY Navin Fluorine International30 Oct 2026 · ~2 weeks · target ₹9,000 · Active
- BUY Saregama India29 Oct 2026 · ~2 weeks · target ₹572 · Active
- BUY WESTLIFE FOODWORLD29 Oct 2026 · ~2 weeks · target ₹660 · Active
- BUY Eternal29 Oct 2026 · ~2 weeks · target ₹360 · Active

